Pathogenesis and Epidemiology of Vulvovaginal Candidiasis

Annals of the New York Academy of Sciences

Volumn 544, Issue 1, 1988, Pages 547-557

  SOBEL, JACK D ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMIDAZOLE DERIVATIVE;

CANDIDA ALBICANS; CANDIDIASIS; DIABETES MELLITUS; EPIDEMIOLOGY; FUNGUS; HOST RESISTANCE; HUMAN; IMMUNE DEFICIENCY; NONHUMAN; PATHOGENESIS; PREGNANCY; PRIORITY JOURNAL; REVIEW; VAGINA; VAGINITIS;

CANDIDA; CANDIDIASIS, VULVOVAGINAL; FEMALE; HUMAN; MALE; PREGNANCY; VIRULENCE;

EID: 0024161456     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1988.tb40450.x     Document Type: Article

References (60)

1. Non‐reported sexually transmitted diseases. 1979
2. Candida and candidiasis: Cultural conditions, epidemiology, and pathogenesis
3. Adult vaginitis
4. Genital yeast infections
5. Establishing the cause of genitourinary symptoms in women in a family practice: Comparison of clinical examination and comprehensive microbiology
6. Candida vaginitis
7. Trends in candidal vaginitis
8. Candidal vaginitis: Natural history, predisposing factors and prevention
9. Recurrent candidal vulvovaginitis
10. Candida tropicalis vulvovaginitis
11. Epidemiological investigations of patients with vulvovaginal candidosis
12. A simple system for the presumptive identification of Candida albicans and differentiation of strains within the species
13. Genital candidosis
14. Analysis of Candida albicans phenotypes from different geographical and anatomical sources
15. Adherence of Candida albicans and other Candida species to mucosal epithelial cells
16. C. albicans adherence to vaginal epithelial cells
17. Recurrent vulvovaginal candidiasis: Vaginal epithelial cell susceptibility to Candida albicans adherence
18. Pathogenesis of vaginal candidiasis: Studies with a mutant which has reduced ability to adhere in vitro.
19. Critical role of germination in the pathogenesis of experimental candidal vaginitis
20. Ketoconazole prophylaxis in experimental vaginal candidiasis
21. High‐frequency switching colony morphology in Candida albicans.
22. Experimental vaginal and cutaneous moniliasis: Clinical and laboratory studies of certain monilias associated with vaginal oral and cutaneous thrush
23. Relationship between cell surface composition of Candida albicans and adherence to acrylic after‐growth on different carbon sources
24. The pill does not cause “thrush.”
25. Vaginal moniliasis after tetracycline therapy
26. Effect of minocycline and tetracycline on the vaginal yeast flora
27. Microbial flora associated with Candida albicans vulvovaginitis
28. β‐Indoleethanol and β‐indolelactic acid production by Candida species: Their antibacterial and autoantibiotic action
29. Recurrent Candida infection
30. Recurrent genital candidosis and iron metabolism
31. Immunoglobulin levels and antibody to Candida albicans in human cervicovaginal secretions
32. Humoral immunity in vaginal candidiasis
33. IgA and IgG antibodies to Candida albicans in the genital tract secretions of women with or without vaginal candidosis
34. Damage to pseudohyphae of Candida albicans by neutrophils in the absence of serum in vitro.
35. Experimental vaginal candidiasis in rats
36. Chronic vaginal candidiasis in women with human immunodeficiency virus infections
37. Microbial interference between indigenous yeast and lactobacilli in the rodent stomach
38. Fungistatic and fungicidal activity of human parotid salivary histidine‐rich polypeptides on Candida albicans.
39. Colonization of Candida albicans in vagina, rectum, and mouth
40. Epidemiology of recurrent vulvovaginal candidiasis: Identification and strain differentiation of Candida albicans.
41. Hyposensitisation in the management of recurring vaginal candidiasis
42. Management of recurrent vulvovaginal candidiasis with intermittent ketoconazole prophylaxis
43. Recurrent vulvovaginal candidiasis: A prospective study of the efficacy of maintenance ketoconazole therapy
44. Recurrent vaginal candidiasis: Importance of an intestinal reservoir
45. Demonstration of typical features of individual Candida albicans strains as a means of studying sources of infection
46. Effect of simultaneous oral and vaginal treatment on the rate of cure and relapse in vaginal candidosis
47. Treatment of vulvovaginal yeast infection with nystatin
48. Carriage of yeasts on the penis
49. How often is genital yeast infection sexually transmitted?
50. Inhibition of Candida albicans‐induced lymphocyte proliferation by lymphocytes and sera from women with recurrent vaginitis
51. Inhibition of Candida‐induced lymphocyte proliferation by antibody to Candida albicans.
52. A macrophage defect in women with recurrent Candida vaginitis and its reversal in vitro by prostaglandin inhibitors
53. Immunological aspects of candidal vaginitis
54. Cellular and humoral immune status in women with chronic Candida vaginitis
55. Hypersensitivity as a cause of dermatologic and vaginal moniliasis resistant to topical therapy